Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Cincinnati OH, St Louis MO, Denver NC, Huntersville NC,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase 2, Recruiting
Active & Responsive
Helix Research Network
for
Genetic Predisposition to Disease, Genetics Disease
Location: Cincinnati OH, Columbus OH, Fort Wayne IN,
Sponsor: Helix, Inc
Sex: All
Age: 18+
Code: NCT06057181
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
Location: Liberty Township OH, Wheelersburg OH, Carmel IN,
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase 3, Recruiting
Active & Responsive
E-diary vs Paper Diary in Binge Eating Disorder
for
Binge Eating Disorder
Location: Mason OH
Sponsor: Lindner Center of HOPE
Sex: All
Age: 0 - 18
Code: NCT07715812
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Mason OH, Plainfield IN, Bowling Green KY, Cleveland OH,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & Responsive
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Mason OH, Charlottesville VA, Atlanta GA, Bryant AR,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06911112
Phase 3, Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Mason OH, Bowling Green KY, Detroit MI, Nashville TN,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase 2, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Franklin OH, Centerville OH, Dayton OH, Greenville OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Franklin OH, Centerville OH, Dayton OH, Greenville OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase 2, Phase 3, Recruiting
Active & Responsive
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Franklin OH, Centerville OH, Dayton OH, Greenville OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05136196
Phase 2, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Franklin OH, Centerville OH, Dayton OH, Greenville OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & Responsive
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Franklin OH, Centerville OH, Dayton OH, Greenville OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06589804
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Springboro OH, Louisville KY, Indianapolis IN, Akron OH,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis